Verrica Pharmaceuticals resubmits application for lead drug candidate
A Chester County pharmaceutical company specializing in developing treatment for skin diseases has resubmitted a new drug application for its lead product candidate after being rejected by the Food and Drug Administration earlier this year.
Verrica Pharmaceuticals (NASDAQ: VRCA) of West Chester resubmitted its application for VP-102, an experimental treatment for molluscum contagiosum.
The company's stock opened up about 2.5% at $12.94 per share Thursday.
“We look forward to working with the…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: John George Source Type: news